About us Pricing ContactSubscribe

K

Kenneth B. Gordon

Northwestern UniversityORCID https://orcid.org/0000-0002-9347-0292

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Guidelines of care for the management of psoriasis and psoriatic arthritis

Journal of the American Academy of Dermatology20081,202 citations

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

Journal of the American Academy of Dermatology2019880 citations

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Journal of the American Academy of Dermatology2007872 citations

Guidelines of care for the management of psoriasis and psoriatic arthritis

Journal of the American Academy of Dermatology2008765 citations

Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial

Journal of the American Academy of Dermatology2017718 citations

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

Journal of the American Academy of Dermatology2015659 citations

Guidelines of care for the management of psoriasis and psoriatic arthritis

Journal of the American Academy of Dermatology2009548 citations

Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up

British Journal of Dermatology2013406 citations

Kenneth B. Gordon · Scinovex